Irhythm Technologies Inc (IRTC) Stock Price, Quote & News

Company Profile

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) moni...

Industry: Medical Devices

Sector: Healthcare

Phone: 415 632 5700

Website: www.irhythmtech.com

Address:

699 8th Street, Suite 600, San Francisco, United States

JR679 Feb. 23 at 6:12 PM

$IRTC

0 · Reply

JR679 Feb. 20 at 1:59 PM

$IRTC

0 · Reply

StocktwitsEarnings Feb. 19 at 9:22 PM

$IRTC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.17 up 525.00% YoY • Reported revenue of $208.89M up 27.12% YoY • For the full year 2026, iRhythm expects revenue of $870M to $880M and adjusted EBITDA margin of 11.5% to 12.5%, reflecting continued volume-led growth and gross margin expansion.

0 · Reply

Estimize Feb. 19 at 4:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +2.40M Revs compared to WS http://www.estimize.com/irtc/fq4-2025?utm_conten

0 · Reply

OfficialStocktwitsUser Feb. 13 at 11:07 AM

$IRTC RSI: 38.21, MACD: -5.8198 Vol: 7.55, MA20: 156.55, MA50: 167.87 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Feb. 12 at 10:14 AM

$IRTC Share Price: $152.14 Contract Selected: Aug 21, 2026 $150 Calls Buy Zone: $18.02 – $22.25 Target Zone: $34.15 – $41.74 Potential Upside: 79% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Feb. 2 at 4:13 PM

$IRTC Share Price: $157.71 Contract Selected: Aug 21, 2026 $170 Calls Buy Zone: $14.96 – $18.48 Target Zone: $25.71 – $31.43 Potential Upside: 62% ROI Time to Expiration: 199 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Jan. 30 at 3:44 PM

$IRTC Share Price: $151.19 Contract Selected: Aug 21, 2026 $145 Calls Buy Zone: $19.80 – $24.47 Target Zone: $34.70 – $42.41 Potential Upside: 65% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Leondog1992 Jan. 30 at 3:23 PM

$APGE $IRTC $MDB $HL $IESC

0 · Reply

Leondog1992 Jan. 29 at 7:04 PM

$FROG $GH $GMED $IRTC $RKT Just remember money and this life is only Temporary. Jesus is king

1 · Reply

iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 4:05 PM EST - 4 days ago

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

Feb 5, 2026, 4:30 PM EST - 18 days ago

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Jan 31, 2026, 6:30 AM EST - 23 days ago

iRhythm: Structural Shift To Profitable Growth

Jan 29, 2026, 5:02 PM EST - 25 days ago

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 23, 2026, 9:08 AM EST - 4 weeks ago

Artisan Small Cap Fund Q4 2025 Portfolio Activity

BRKR CLBT FLEX GH HXL INSM ITGR

Jan 19, 2026, 10:30 PM EST - 5 weeks ago

Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity

ALAB ARGX COHR CRM CVNA DASH FERG

Jan 15, 2026, 11:22 AM EST - 5 weeks ago

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 14, 2026, 12:43 PM EST - 5 weeks ago

iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst

Jan 12, 2026, 1:46 PM EST - 6 weeks ago

iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:30 AM EST - 6 weeks ago

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:30 PM EST - 2 months ago

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 3:53 PM EST - 2 months ago

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 13, 2025, 5:00 PM EST - 3 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC

Nov 11, 2025, 8:05 AM EST - 3 months ago

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

Nov 5, 2025, 1:38 PM EST - 3 months ago

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

Nov 4, 2025, 4:30 PM EST - 3 months ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

Oct 31, 2025, 2:17 PM EDT - 4 months ago

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

Oct 30, 2025, 9:06 PM EDT - 4 months ago

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 4:05 PM EDT - 4 months ago

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Oct 16, 2025, 4:30 PM EDT - 4 months ago

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

Sep 18, 2025, 1:30 PM EDT - 5 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

Sep 9, 2025, 5:01 PM EDT - 5 months ago

IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 29, 2025, 7:00 AM EDT - 6 months ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Aug 18, 2025, 12:53 PM EDT - 6 months ago

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies

Aug 18, 2025, 8:05 AM EDT - 6 months ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

Jul 31, 2025, 9:49 PM EDT - 7 months ago

iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 7 months ago

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Jul 25, 2025, 6:35 PM EDT - 7 months ago

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 17, 2025, 4:30 PM EDT - 7 months ago

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 11, 2025, 10:12 PM EDT - 8 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 7, 2025, 8:30 AM EDT - 8 months ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Jun 23, 2025, 8:30 AM EDT - 8 months ago

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 17, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Jun 15, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 9 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 10, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Jun 8, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

Jun 5, 2025, 10:00 AM EDT - 9 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

May 2, 2025, 1:24 PM EDT - 10 months ago

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

May 1, 2025, 9:14 PM EDT - 10 months ago

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:10 PM EDT - 10 months ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

Apr 29, 2025, 6:05 PM EDT - 10 months ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 8:05 AM EDT - 10 months ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 17, 2025, 4:30 PM EDT - 11 months ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 16, 2025, 8:35 AM EDT - 11 months ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

JR679 Feb. 23 at 6:12 PM

$IRTC

0 · Reply

JR679 Feb. 20 at 1:59 PM

$IRTC

0 · Reply

StocktwitsEarnings Feb. 19 at 9:22 PM

0 · Reply

Estimize Feb. 19 at 4:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +2.40M Revs compared to WS http://www.estimize.com/irtc/fq4-2025?utm_conten

0 · Reply

OfficialStocktwitsUser Feb. 13 at 11:07 AM

0 · Reply

SuperGreenToday Feb. 12 at 10:14 AM

0 · Reply

SuperGreenToday Feb. 2 at 4:13 PM

0 · Reply

SuperGreenToday Jan. 30 at 3:44 PM

0 · Reply

Leondog1992 Jan. 30 at 3:23 PM

$APGE $IRTC $MDB $HL $IESC

0 · Reply

Leondog1992 Jan. 29 at 7:04 PM

$FROG $GH $GMED $IRTC $RKT Just remember money and this life is only Temporary. Jesus is king

1 · Reply

Leondog1992 Jan. 29 at 4:43 PM

$FROG $RKT $GH $IRTC $GMED

1 · Reply

Leondog1992 Jan. 29 at 2:46 PM

$IRTC

0 · Reply

StockHunter75 Jan. 27 at 2:23 PM

$IRTC Bullish 🐂

0 · Reply

OfficialStocktwitsUser Jan. 19 at 12:43 PM

$IRTC RSI: 43.68, MACD: -2.1351 Vol: 8.24, MA20: 175.76, MA50: 175.72 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

TICKERSPARK Jan. 14 at 1:15 AM

iRhythm $IRTC hit 4x volume after management recalibrated guidance. Volume around a guidance reset rewrites the risk map.

0 · Reply

Okadarlan Jan. 13 at 5:23 PM

$IRTC bankrupt in March 2027 @IjustTradeiT @DonCorleone77 mark it .

0 · Reply

BolsterBaron Dec. 26 at 8:23 AM

$IRTC Volatility reflects unresolved questions around how strategy converts into durable results. Forecast reliability will be tested repeatedly. Guidance slippage would be magnified by the market. Consistency will matter more than short-term excitement.

0 · Reply

TaxEfficientInvest Dec. 25 at 3:57 PM

$IRTC Forward returns depend heavily on whether management can deliver consistent operational results. Cash flow visibility will determine how patient investors remain. A series of confirmed wins might reduce the required risk premium. Absent confirmation, volatility is likely to persist.

0 · Reply

WallStreetBuyDip Dec. 25 at 3:46 AM

$IRTC Massive volume increase with 822,600 shares traded on Dec 19, 2025, as price hit $174.17. Recent price range from $168.48 to $179.65. Smart money waits for lower H% before entering.

0 · Reply

WallStreetBuyDip Dec. 24 at 10:42 PM

Comparing trending tickers $IRTC vs $OPGN: IRTC is currently at $175.80, down by 1.49%, on a trading volume of 182.1K shares, which is below its average of 455.3K. On the other hand, OPGN has risen by 7.22%, reaching $15.00, with a volume of only 1.7K compared to its usual 8.1K. While OPGN has shown a significant price increase on relatively low volume, IRTC's price has declined despite a higher trading volume, albeit still below its average.

0 · Reply

WallStreetBuyDip Dec. 24 at 10:12 PM

Comparing trending tickers $GLSI vs $IRTC: GLSI is up 18.12% today, hitting $17.21 with a substantial volume increase to 461.8K shares, which is over 5 times its average volume. In contrast, IRTC is down 1.49% at $175.80, trading 181.2K shares, which is actually below its usual volume of 455.3K. Clearly, GLSI is experiencing a significant surge both in price and trading activity, whereas IRTC is seeing a dip in both its stock price and volume.

0 · Reply

JarvisFlow Dec. 24 at 7:35 PM

Oppenheimer has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Outperform with a target price of 125 → 165.

0 · Reply

Market Cap	5.78B
Revenue (ttm)	591.84M
Net Income (ttm)	-113.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.14%
Debt to Equity Ratio	0.00

Volume	1,454,100
Avg Vol	495,702
Day's Range	N/A - N/A
Shares Out	32.22M
Stochastic %K	35%
Beta	1.12
Analysts	Strong Sell
Price Target	$219.64